Stabilin-1+/SMA- macrophages in diagnostics of postinfarction tissue inflammation associated with adverse cardiac remodeling in patients with myocardial infarction

被引：0
|
作者：
Gombozhapova, A. [1 ]
Rogovskaya, Y. [1 ]
Rebenkova, M. [1 ]
Kzhyshkowska, J. [2 ]
Ryabov, V [1 ]
机构：
[1] Tomsk NRMC, Cardiol Res Inst, Tomsk, Russia
[2] Natl Res Tomsk State Univ, Tomsk, Russia
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：917 / 917
页数：1
相关论文
共 50 条
  • [41] Efferocytic Regulator Rab11FIP1 Alleviates Inflammation and Cardiac Remodeling After Myocardial Infarction
    Zhuang, Lingfang
    Zhang, Ruiyan
    Chen, Kang
    Yan, Xiaoxiang
    CIRCULATION, 2023, 148
  • [42] Sphingosine 1-phosphate Signaling Contributes To Cardiac Inflammation, Remodeling And Dysfunction Following Myocardial Infarction.
    Zhang Fuyang
    Xia Yunlong
    Wang Wei
    Yan Wenjun
    Yang Lu
    Li Yan
    Zhou Fen
    Tao Ling
    CIRCULATION RESEARCH, 2014, 115
  • [43] Myocardial Production of Follistatin-Like 1 is Associated With Left Ventricular Adverse Remodeling in Survivors of Acute Myocardial Infarction.
    Uematsu, Manabu
    Nakamura, Kazuto
    Nakamura, Takamitsu
    Yoshizaki, Toru
    Watanabe, Yosuke
    Deyama, Juntaro
    Watanabe, Kazuhiro
    Kobayashi, Tsuyoshi
    Fujioka, Daisuke
    Saito, Yukio
    Kawabata, Kenichi
    Obata, Jun-ei
    Kugiyama, Kiyotaka
    CIRCULATION, 2018, 138
  • [44] Oncostatin M is associated with adverse left ventricular remodeling in patients with ST-segment elevation myocardial infarction
    Gusakova, A. M.
    Kercheva, M. A.
    Ryabova, T. R.
    Suslova, T. E.
    Ryabov, V. V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1366 - 1366
  • [45] Cardiac adverse events associated with statins in myocardial infarction patients: a pharmacovigilance analysis of the FDA Adverse Event Reporting System
    Deng, Chuanhuan
    Lin, Xiaofang
    Ni, Dan
    Yuan, Ludong
    Li, Jing
    Liu, Yuxuan
    Liang, Pengfei
    Jiang, Bimei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, 47 (01) : 46 - 52
  • [46] Myofibroblast Smad1 Activation Restrains Cardiac Fibrosis and Attenuates Post-Myocardial Infarction Adverse Remodeling
    Hanna, Anis
    Frangogiannis, Nikolaos
    CIRCULATION, 2021, 144
  • [47] TRPV1 gene deletion increases mortality rate, inflammation, and disproportional cardiac remodeling after myocardial infarction
    Huang, Wei
    Rubinstein, Jack
    Prieto, Alejandro R.
    Wang, Donna H.
    HYPERTENSION, 2008, 52 (04) : E46 - E46
  • [48] Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction
    Bageghni, Sumia A.
    Hemmings, Karen E.
    Yuldasheva, Nadira Y.
    Maqbool, Azhar
    Gamboa-Esteves, Filomena O.
    Humphreys, Neil E.
    Jackson, Maj Simonsen
    Denton, Christopher P.
    Francis, Sheila
    Porter, Karen E.
    Ainscough, Justin F. X.
    Pinteaux, Emmanuel
    Drinkhill, Mark J.
    Turner, Neil A.
    JCI INSIGHT, 2019, 4 (17)
  • [49] Low sCD163/TWEAK Ratio at First Day After Acute Myocardial Infarction Associated with Adverse Cardiac Remodeling in Non-Elderly Patients
    Altintas, Mehmet Sait
    Eyerci, Nilnur
    Karayigit, Orhan
    Demirtas, Bekir
    Gok, Murat
    Kiziltunc, Emrullah
    KARDIOLOGIYA, 2022, 62 (10) : 49 - 55
  • [50] Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
    Celestino Sardu
    Nunzia D’Onofrio
    Michele Torella
    Michele Portoghese
    Francesco Loreni
    Simone Mureddu
    Giuseppe Signoriello
    Lucia Scisciola
    Michelangela Barbieri
    Maria Rosaria Rizzo
    Marilena Galdiero
    Marisa De Feo
    Maria Luisa Balestrieri
    Giuseppe Paolisso
    Raffaele Marfella
    Cardiovascular Diabetology, 18
12345